MAPT and Alzheimer disease: Additionally, the average participants, aged 66.2 in CADS and 66.6 in GHABS, are relatively younger than the typical age of late 70s, suggesting that some early‐onset AD patients with higher levels of amyloid and tau pathology were also included in this study.